Tri-Rage

Stanozolol Depot, Testosterone Propionate, Trenbolone Acetate · 250 mg / 10 ml

XPharma Tri-Rage product presentation

Tri-Rage

Active compound
Stanozolol Depot, Testosterone Propionate, Trenbolone Acetate
Presentation
250 mg / 10 ml

Tri-Rage is an injectable blend presentation based on Stanozolol Depot, Testosterone Propionate, and Trenbolone Acetate, as identified on the product label. The label describes a combined composition of 50 mg Stanozolol Depot, 100 mg Testosterone Propionate, and 100 mg Trenbolone Acetate in a 250 mg / 10 ml presentation. These compounds are commonly referenced in technical compound references for androgen receptor activity, anabolic-androgenic profile, and blend classification.

This product is organized within the XPharma catalog for product identification, label review, commercial reference, and documentation requests.

This page does not provide usage guidance, medical advice, or performance claims. Composition, regulatory status, market availability, and supporting documentation should be confirmed through official XPharma channels.

Important Notice

This page provides institutional and commercial information only. Product details, availability, documentation status, and market-specific requirements vary by product and market and must be confirmed through official XPharma channels. Nothing on this page should be interpreted as professional health guidance, a health-condition claim, or commercial authorization in any specific country.